From EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials:

EyeGate Device

EyeGate Device—

The EyeGate II device. Photo courtesy of Eyegate: http://www.eyegatepharma.com/technology/

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

From Our Editors · Podcast
Xcelerating Life Sciences San Francisco: The Highlights Podcast
The AI, Big Data, and R&D Boom

Xconomy on Demand

We offer a number of ways to subscribe for free!